Trogarzo Injection, Solution
Product Images NDC 62064-122

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Trogarzo (NDC 62064-122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Theratechnologies Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Trogarzo Vial Label)

TROGARZO (ibalizumab-uiyk) Injection label showing 200 mg/1.33 mL (150 mg/mL) concentration. It is indicated for intravenous infusion only, supplied as a single-dose vial with instructions to discard unused portions. The label includes storage instructions at 2° to 8°C (36°-46°F), protection from light, and a reference to prescribing information. Labeler is Theratechnologies Inc.*

FDA Label Image

Principal Display Panel (Trogarzo Carton Label)

Flat carton packaging label for TROGARZO injection, solution 200 mg/1.33 mL (150 mg/mL) by Theratechnologies Inc. The label states intravenous infusion use, single-dose vial with discard instructions. Includes product name, generic name ibalizumab-uiyk, manufacturer information in Montreal, Canada, and warnings about child safety and vial seal integrity. Barcode and lot/expiration date areas are present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.